Avinger
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Avinger sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Avinger: 6 sponsored US clinical trials, 1 recruiting.
Avinger sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Peripheral Arterial Disease, with 1 trials.
Upper-quartile sponsor footprint
Avinger sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Assessment of the Utility of the Pantheris Small Vessel (SV) System
NCT04793581
Evaluation of Imaging of Peripheral Arteries by Optical Coherence Tomography and Intravascular Ultrasound Imaging
NCT03480685
Pantheris Atherectomy Treatment of In-Stent Restenosis In Lower Extremity Arteries
NCT03192696
Evaluation of the Pantheris Atherectomy System
NCT01937351
Chronic Total Occlusion Crossing With the Ocelot System - CONNECT II
NCT01537302
Chronic Total Occlusion Crossing With the Wildcat Catheter
NCT01174784
Therapeutic Areas
What is open in the Avinger pipeline
1 recruiting of 6 indexed (17% open); 5 completed (83%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Peripheral Arterial Disease (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Avinger: open-pipeline peers nationwide
Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Avinger sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this Avinger page
6 registered trials is a research-attention snapshot, not an endorsement of Avinger or any single study.
- 1 of Avinger's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Peripheral Arterial Disease is the condition Avinger studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Peripheral Arterial Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Avinger pipeline card: 6 registered trials from official public datasets.Report a data error.